Aspira Pathlab & Diagnostics

Aspira Pathlab & Diagnostics Dividend

Dividend of Aspira Pathlab & Diagnostics (540788.BO) as of Nov 8, 2026.

Dividend

0.00INR

Last updated:

How much dividend does Aspira Pathlab & Diagnostics 2026 pay?

According to the latest status from November 2026, Aspira Pathlab & Diagnostics paid a total of 0.00 INR per share in dividends within the last 12 months. With the current Aspira Pathlab & Diagnostics price of 133.60 INR, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Aspira Pathlab & Diagnostics Dividends

Historical Aspira Pathlab & Diagnostics Dividends
PaydateDividend

The Aspira Pathlab & Diagnostics Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2018
0.00 INR
Jan 1, 2019
0.00 INR
Jan 1, 2020
0.00 INR
Jan 1, 2021
0.00 INR
Jan 1, 2022
0.00 INR
Jan 1, 2023
0.00 INR
Jan 1, 2024
0.00 INR
Jan 1, 2025
0.00 INR
The Aspira Pathlab & Diagnostics Dividend history
YEARDividendYoY
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—

Is the Aspira Pathlab & Diagnostics Dividend Safe?

Aspira Pathlab & Diagnostics has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Aspira Pathlab & Diagnostics's Dividend Distributions

Aspira Pathlab & Diagnostics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Aspira Pathlab & Diagnostics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Aspira Pathlab & Diagnostics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Aspira Pathlab & Diagnostics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Aspira Pathlab & Diagnostics Stock analysis

What does Aspira Pathlab & Diagnostics do? Aspira Pathlab & Diagnostics Ltd generates revenue through pathology investigation services, radiology investigation services, and health packages at its diagnostic centers in Mumbai. The company offers specialized tests such as the Shanti Screening Test, COVID-19 Antibody Test, and COVID-19 RT-PCR Test, which are part of its diagnostic services portfolio. Customers include individuals seeking health screenings, patients requiring medical diagnostics, and healthcare providers who refer clients to its facilities. The firm's services are segmented into pathology, radiology, and health packages, with a focus on high-demand tests like COVID-19 detection profiles. The company's revenue streams are derived from conducting various pathological investigations across branches like biochemistry, hematology, and microbiology. Its health packages and pathology tests, including the COVID-19 Detection Profile 1 and 2, cater to both individual and institutional clients. The firm operates within the healthcare sector, providing diagnostic solutions for patients and medical professionals in Mumbai, with a particular emphasis on pandemic-related testing services during the global health crisis. Aspira Pathlab & Diagnostics Ltd monetizes its diagnostic capabilities through a mix of routine pathology services and specialized health packages. The Shanti Screening Test and other COVID-19-related tests form a significant portion of its revenue, especially during periods of high demand for pandemic testing. The company serves a broad customer base, including individuals, clinics, and hospitals that rely on its diagnostic expertise for accurate medical assessments. Aspira Pathlab & Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aspira Pathlab & Diagnostics stock

Aspira Pathlab & Diagnostics paid dividends every year for the past 0 years.

Aspira Pathlab & Diagnostics is assigned to the '—' sector.

The dividends of Aspira Pathlab & Diagnostics are distributed in INR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Aspira Pathlab & Diagnostics